Di-Chem, Incorporated

Midwest Special Services, located in St. Paul, Minn., is a nonprofit organization that offers specialized programs for individuals with a wide range of disabilities. Its programs are for adults over the age of 18 and its services area covers the seven county Minneapolis Metro Area. MSS offers vocational programs, personal care assistance, onsite nursing services, art activities, swimming, transportation, individual performance programs, job coaching, physical therapy and occupational therapy. More than 90% of its enrolled individuals choose vocational work opportunities offered as part of a personal achievement plan. MSS operates licensed facilities in Hennepin, Ramsey and Dakota counties in Minnesota.

Northern Technologies International Corporation is an American Stock Exchange listed company with representatives in more than 45 countries, including eight research and design facilities. The Company focuses on developing, marketing and selling proprietary environmentally responsible materials science-based products and technical services. Since 1976, the company has been in the business of corrosion management, utilizing a full range of corrosion inhibiting technologies under the brand name Zerust. Northern Technologies International Corporation s products and services include proprietary corrosion inhibiting packaging products, patented cathodic protection technologies and anti-corrosion coatings. These products are suitable for automotive, electronics, marine, military, mechanical and electrical applications. Northern Technologies International Corporation is headquartered in Circle Pines, Minn.

SurModics is a provider of surface modification and drug delivery solutions for the health care industry. One of SurModics core technology platforms is its patented drug delivery polymer matrix technology, which can be applied to medical devices to deliver pharmaceutical agents from the surface of a device to a targeted area of the body. For example, SurModics' Bravo drug delivery polymer matrix is used in the first-to-market drug eluting coronary stent and is being used in the I-vation Intravitreal implant. Another core surface modification technology platform is its patented PhotoLink process, which helps modify and enhance the surface characteristics of medical devices and biomedical applications improving performance and, in some cases, enabling the development of new products. The company also produces stabilization products used by manufacturers of immunoassay diagnostic tests to improve performance, stability and shelf life. SurModics is headquartered in Eden Prairie, Minn.